Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN‐DBS) in Parkinson disease. Methods: Clinical and genetic data from 12 datasets were examined. Global cognition was assessed using the Mattis Dementia Rating Scale (MDRS). Subjects were examined for mutations in GBA and categorized as GBA carriers with or without DBS (GBA+DBS+, GBA+DBS‐), and noncarriers with or without DBS (GBA‐DBS+, GBA‐DBS‐). GBA mutation carriers were subcategorized according to mutation severity (risk variant, mild, severe). Linear mixed modeling was used to compare rate of change in MDRS scores over time among the groups according to GBA and DBS status and then according to GBA severity and DBS status. Results: Data were available for 366 subjects (58 GBA+DBS+, 82 GBA+DBS‐, 98 GBA‐DBS+, and 128 GBA‐DBS‐ subjects), who were longitudinally followed (range = 36–60 months after surgery). Using the MDRS, GBA+DBS+ subjects declined on average 2.02 points/yr more than GBA‐DBS‐ subjects (95% confidence interval [CI] = −2.35 to −1.69), 1.71 points/yr more than GBA+DBS‐ subjects (95% CI = −2.14 to −1.28), and 1.49 points/yr more than GBA‐DBS+ subjects (95% CI = −1.80 to −1.18). Interpretation: Although not randomized, this composite analysis suggests that the combined effects of GBA mutations and STN‐DBS negatively impact cognition. We advise that DBS candidates be screened for GBA mutations as part of the presurgical decision‐making process. We advise that GBA mutation carriers be counseled regarding potential risks associated with STN‐DBS so that alternative options may be considered. ANN NEUROL 2022;91:424–435
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationRegression to the mean: what it is and how to deal with it
Barnett, A. G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh299 · Cited by 1,988 · cited 1×
“Furthermore, we have on average >2 time points per subject, which reduces the likelihood of regression to the mean.(50) Ultimately, additional studies are needed to confirm our results and their impact on quality of life.”
BackgroundStatistical primer: propensity score matching and its alternatives
Benedetto, U., Head, S. J., Angelini, G. D., & Blackstone, E. H. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy167 · Cited by 695 · cited 1×
“This discrepancy could be secondary to the small sample size in these groups, a scenario where the utility of the propensity score weighting technique may be limited.(49) Strengths of our study include a large sample size, international collaboration, long duration of follow-up, and use of mixed effects model analysis.”
BackgroundA fronto–striato–subthalamic–pallidal network for goal-directed and habitual inhibition
Jahanshahi, M., Obeso, I., Rothwell, J. C., & Obeso, J. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4038 · Cited by 521 · cited 2×
“STN-DBS has been associated with a negative impact on timed tasks such as verbal fluency,(10) executive control of action,(11) and inhibitory control.(12) Further studies are needed to determine whether these cognitive processes or other specific domains are affected in those with STNDBS and GBA mutations.”
BackgroundStefurak, T., Mikulis, D., Mayberg, H., Lang, A. E., Hevenor, S., Pahapill, P., Saint‐Cyr, J., & Lozano, A. (2003) · Movement Disorders · doi:10.1002/mds.10593 · Cited by 215 · cited 5×
“Imaging studies have revealed the likely region of accidental activation is that of nonmotor medial prefrontal–striatal circuitry in those with STN-DBS.(15) Future studies can potentially examine the effects of GPi-DBS in this cognitively vulnerable population.”
BackgroundResultInfluentialAcute severe depression induced by intraoperative stimulation of the substantia nigra: a case report
Blomstedt, P., Hariz, M. I., Lees, A., Silberstein, P., Limousin, P., Yelnik, J., & Agid, Y. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.04.005 · Cited by 62 · cited 2×
“Given the compact anatomy of STN compared with GPi, the likelihood is higher of unintended current spread into adjacent STN subregions and nearby structures.(13,14) Imaging studies have revealed the likely region of accidental activation is that of nonmotor medial prefrontal–striatal circuitry in those with STN-DBS.”
Background
Cited by
Deep brain stimulation for Parkinson's disease
Hariz, M., & Blomstedt, P. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13541 · Cited by 256
Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study
Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Foroud, T., Hall, A., Marder, K. S., Mata, I. F., Mencacci, N. E., Nance, M. A., et al. (2024) · Brain · doi:10.1093/brain/awae142 · Cited by 108
“…genetic status 11,18 ; (ii) different genetic forms of Parkinson’s disease can have strikingly different prognoses 4 ; (iii) emerging evidence that genotype may be relevant for aspects of clinical care 28 ; and (iv) gen-etic status can determine eligibility for precision medicine clinical trials.”
BackgroundSelf-citationThe functional differentiation of brain–computer interfaces (BCIs) and its ethical implications
Sun, X.-Y., & Ye, B. (2023) · Humanities and Social Sciences Communications · doi:10.1057/s41599-023-02419-x · Cited by 29
Hanlon, C. A., Lench, D. H., Pell, G., Roth, Y., Zangen, A., & Tendler, A. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1336027 · Cited by 7
Metadata
- Authors
- Pal, G., Mangone, G., Hill, E. J., Ouyang, B., Liu, Y., Lythe, V., Ehrlich, D., Saunders‐Pullman, R., Shanker, V., Bressman, S., Alcalay, R. N., Garcia, P., Marder, K. S., Aasly, J., Mouradian, M. M., Link, S., Rosenbaum, M., Anderson, S., Bernard, B., Wilson, R., Stebbins, G., Nichols, W. C., Welter, M., Sani, S., Afshari, M., Verhagen, L., de Bie, R. M. A., Foltynie, T., Hall, D., Corvol, J., & Goetz, C. G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2022-01-25
- Volume
- 91
- Issue
- 3
- Pages
- 424-435
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W4206181210
- Cited by
- 104
- References
- 7
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.